Literature DB >> 6673075

Plasma concentration of vasoactive intestinal polypeptide during prolonged physical exercise, calorie supply deficiency, and sleep deprivation.

O Oktedalen, P K Opstad, J Fahrenkrug, F Fonnum.   

Abstract

Twenty-four military cadets went through a 5-day period of heavy physical exercise (35% of max O2 uptake), severe calorie supply deficiency (about 36,000 kJ/24 h), and sleep deprivation (2 h of sleep as a total during 5 days). Some cadets compensated for the caloric deficiency, whereas others partly compensated for the sleep deprivation. Fasting and meal- and glucose-induced changes in the plasma concentration of vasoactive intestinal polypeptide (VIP) were measured on separate days during the course and 8 h after the course was finished (day 6). Fasting plasma concentration of VIP increased two- to five-fold during the course, with the highest increase on day 2. The calorie-compensated subjects showed a smaller increase than those who did not receive any calorie or sleep compensation. Intake of a meal or glucose solution lowered the VIP concentration in plasma within 30-60 min to the concentrations found in the control experiments performed several weeks after the course. The results indicate a role of VIP as 'a polypeptide of substrate need'.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6673075     DOI: 10.3109/00365528309181840

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  4 in total

1.  Glycogenolytic effect of vasoactive intestinal peptide in the rat in vivo.

Authors:  V Sánchez; R Goberna; J R Calvo
Journal:  Experientia       Date:  1991-06-15

2.  The plasma concentrations of secretin and vasoactive intestinal polypeptide (VIP) after long-term, strenuous exercise.

Authors:  O Oktedalen; P K Opstad; O B Schaffalitzky de Muckadell
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1983

3.  Physiological changes and gastro-intestinal symptoms as a result of ultra-endurance running.

Authors:  N J Rehrer; F Brouns; E J Beckers; W O Frey; B Villiger; C J Riddoch; P P Menheere; W H Saris
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1992

4.  Physical activity and natural anti-VIP antibodies: potential role in breast and prostate cancer therapy.

Authors:  Milena Veljkovic; Violeta Dopsaj; Milivoj Dopsaj; Donald R Branch; Nevena Veljkovic; Maria M Sakarellos-Daitsiotis; Veljko Veljkovic; Sanja Glisic; Alfonso Colombatti
Journal:  PLoS One       Date:  2011-11-30       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.